Holdings

Elmind Capital, LP

As of Sep 30, 2026, Elmind Capital, LP reported 28 positions worth US$369M. Largest: Celldex Therapeutics, Inc., Legend Biotech Corp. and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Celldex Therapeutics, Inc.1.11MUS$36M+120KSep 30, 2026
Legend Biotech Corp.1.57MUS$31.2MnewSep 30, 2026
Syndax Pharmaceuticals, Inc.1.6MUS$30.2M−250KSep 30, 2026
Cogent Biosciences, Inc.867KUS$27.8M−304KSep 30, 2026
Relay Therapeutics, Inc.1.47MUS$26.4Mno changeSep 30, 2026
Amylyx Pharmaceuticals, Inc.895KUS$26M+783KSep 30, 2026
Viridian Therapeutics, Inc.1.22MUS$25.2M+240KSep 30, 2026
Vaxcyte, Inc.372KUS$21.2M−80,000Sep 30, 2026
Travere Therapeutics, Inc.323KUS$19M+30,000Sep 30, 2026
Cullinan Therapeutics, Inc.963KUS$14.8M+273KSep 30, 2026